![Christopher Murray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Murray
Plus aucun poste en cours
Profil
Christopher K.
Murray worked at ARIAD Pharmaceuticals, Inc. from 2004 to 2017, serving as Vice President-Technical Operations from 2013 to 2017.
Dr. Murray worked at Blueprint Medicines Corp.
from 2017 to 2025, serving as Chief Technical Operations & Quality Officer.
Dr. Murray completed undergraduate studies at Hope College in 1984 and graduate studies at The University of Chicago in 1990.
Dernières actualités sur Christopher Murray
Anciens postes connus de Christopher Murray
| Sociétés | Poste | Fin |
|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Directeur Technique/Scientifique/R&D | 01/04/2025 |
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2017 |
Formation de Christopher Murray
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Hope College
 Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
